Crossed Total Hemiatrophy Associated with Atrophoderma of Pasini-Pierini.
Crossed Total Hemiatrophy Associated with Atrophoderma of Pasini-Pierini. Skinmed. 2017;15(3):227-229 Authors: Zhang RZ, Zhu WY Abstract A 45-year-old Chinese man had begun to show asymmetry of the face 30 years previously. Subsequently, he developed visual extinction of the right eye, slight numbness, and weakness of the left extremities. Simultaneously, multiple atrophic brownish patches occurred on his side. He denied prior trauma or tick bites at those sites. There was no report of preceding redness, induration, or a history of trauma. The atrophic lesions extended and enlarged slowly. Ten years previously, some brownish patches with normal texture had appeared on the right side of the trunk. There was no further progression of the lesions. In November 2010, the patient consulted our department for the final diagnosis and prognosis of his disease. He did not suffer from epileptic seizures and had no history of a tick bite or Lyme disease. PMID: 28705290 [PubMed - in process]
Publication date: Available online 17 September 2020Source: Stem Cell ResearchAuthor(s): Huifang Zhao, Lang He, Hualin Huang, Shuai Li, Na Cheng, Feng Tang, Xiaobo Han, Zuoxian Lin, Rongqi Huang, Peng Zhou, Sihao Deng, Jufang Huang, Zhiyuan Li
Authors: Liao S, Zhang Z, Li G, Zhou L, Jiang J, Zhang N, Wang Y, Du Y, Wen Z Abstract Introduction. Stable angina (SA) in coronary heart disease is a common ischemic heart disease endangering the patient's quality of life and longevity. Clinical trials have demonstrated that the Chinese herbal formula Xuefu Zhuyu (XFZY) has benefits for SA patients. However, there remains a lack of high-quality evidence to support clinical decision-making. Therefore, we designed a randomized controlled trial (RCT) to evaluate the efficacy and safety of XFZY for SA. Methods and Analysis. This multicenter, double-blinded RCT will be...
Publication date: Available online 18 September 2020Source: Electronic Journal of BiotechnologyAuthor(s): Saumel Pérez-Rodriguez, Octavio T. Ramírez, Mauricio A. Trujillo-Roldán, Norma A. Valdez-Cruz
Publication date: Available online 18 September 2020Source: Chinese Journal of Chemical EngineeringAuthor(s): Qi Zhang, Zhaoliang Cui, Weixing Li
Publication date: Available online 18 September 2020Source: Chinese Journal of Chemical EngineeringAuthor(s): Xinxiao Sun, Xianglai Li, Xiaolin Shen, Jia Wang, Qipeng Yuan
Publication date: Available online 18 September 2020Source: Chinese Journal of Chemical EngineeringAuthor(s): Nanhang Dong, Ruiqiang Huo, Ming Liu, Lisheng Deng, Zhengbing Deng, Guozhang Chang, Zhen Huang, Hongyu Huang
CONCLUSIONS Telemedicine reduced the delay time of STEMI patients during the COVID-19 pandemic. The difference in short-term adverse clinical outcomes was not statistically significant between patients who used the app and those who did not. PMID: 32938901 [PubMed - in process]
Publication date: Available online 17 September 2020Source: LinguaAuthor(s): Yaqing Chen, Qunhu Gong
Feng Zhang, Xiaojian Yin, Cunjian Bi, Yuqiang Li, Yi Sun, Ting Zhang, Xiaofang Yang, Ming Li, Yuan Liu, Junfang Cao, Ting Yang, Yaru Guo, Ge Song
Science is just beginning to understand how important your mitochondria are to warding off the diseases of aging. And, as usual, mainstream medicine is lagging way behind. Along with your telomeres, the cellular time keepers at the ends of your chromosomes, your mitochondria are another key component of the anti-aging equation. You see, these tiny organelles in your cells are the power plants that turn fuel into energy for your body. Healthy mitochondria keep you young and energetic. Research shows that damaged mitochondria can lead to: Schizophrenia and bipolar disorder; Alzheimer’s and Parkinson’s d...